Akero Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€35.50M - R&D expenses
€241.95M - EBITDA
-€250.70M - D&A
€13.81K - EBIT
-€277.45M - Interest expenses
€2.13M - EBT
-€245.07M - Tax expenses
€0.00 - Net income
-€245.07M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€7.28M - Changes in working capital
€6.99M - Operating cash flow
-€218.71M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
-€271.43M - Total cash dividends paid
€0.00 - Issuance of common stock
€377.55M - Debt repayment
€0.00 - Other financing cash flow
€24.68M - Net financing cash flow
€412.55M - Foreign exchange effects
€0.00 - Net change in cash
-€77.59M - Cash at end of period
€190.26M - Free cash flow
-€218.71M
Balance sheet
- Cash and cash equivalents
€190.26M - Cash and short-term investments
€640.64M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€19.23M - Total current assets
€659.88M - Property, plant & equipment
€535.95K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€296.82M - Other non-current assets
€0.00 - Total non-current assets
€297.36M - Total assets
€957.24M - Accounts payable
€11.43M - Short-term debt
€12.65M - Other current liabilities
€28.04M - Total current liabilities
€52.13M - Long-term debt
€19.45M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€345.21K - Total non-current liabilities
€19.79M - Total liabilities
€71.92M - Common stock
€6.90K - Retained earnings
-€834.89M - Other equity
€852.68K - Total equity
€885.32M - Total liabilities and shareholders' equity
€957.24M
Company information
- Market capitalization
€3.82B - Employees
69 - Enterprise Value
€4.04B
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-27.7% Much better than peer group: -54.2% - ROA
-
-25.6% Much better than peer group: -47.5% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-5.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€3.55M